文献速递冠心病心力衰竭与心肌病

IABP在急性心肌梗死合并心原性休克中的疗效存在性别差异

[Gender difference in efficacy of intra-aortic balloon pump in acute myocardial infarction patients complicating with cardiogenic shock].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2020-01-01

该回顾性研究纳入阜外医院209例急性心肌梗死合并心原性休克患者,分析IABP疗效的性别差异。结果显示,男性患者接受IABP后28天生存率显著提高,全因死亡风险降低(HR=0.44,95%CI 0.25~0.77,P=0.004),而女性患者无显著获益,性别与IABP疗效存在交互作用(Z=-2.32,P=0.020)。

要点

  • 男性AMI合并心原性休克患者接受IABP可降低28天全因死亡风险(HR=0.44)。
  • 女性患者接受IABP未见28天生存率显著改善(P=0.889)。
  • 性别与IABP疗效存在显著交互作用(Z=-2.32,P=0.020)。

核心结论

  • 在AMI并发心原性休克患者中,IABP植入对28天死亡风险的影响存在性别差异,仅在男性患者中表现出保护作用。

研究设计与样本

  • 回顾性队列研究,纳入2012年6月至2018年5月阜外医院收治的AMI合并心原性休克患者共209例,其中男性148例、女性61例,接受IABP治疗者102例。

主要发现

  • 男性患者28天生存率高于女性(39.2% vs. 26.2%,Log-rank P=0.034)。
  • 女性患者中接受与未接受IABP的28天生存率差异无统计学意义(P=0.889);男性患者中接受IABP者28天生存率高于未接受者(51.2% vs. 25.0%,P=0.001)。
  • 调整混杂因素后,男性患者IABP治疗降低28天全因死亡风险(HR=0.44,95%CI 0.25~0.77,P=0.004),女性患者无影响(P=0.401),性别与IABP疗效存在交互作用(Z=-2.32,P=0.020)。

临床怎么用

  • 在AMI合并心原性休克患者中,应关注性别对IABP疗效的潜在影响,男性患者可能从IABP治疗中获益更明显。

局限性

  • 本研究为单中心回顾性研究,样本量有限,结论需进一步前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the effect of gender on the efficacy of intra-aortic balloon pump(IABP) applied in patients with cardiogenic shock complicated by acute myocardial infarction(AMI). Methods: A total of 209 patients diagnosed as cardiogenic shock complicated by AMI admitted in Fuwai Hospital from June 2012 to May 2018 were enrolled in our study. We collected the data from medical records and investigated their clinical manifestation and laboratory examination and IABP support, as well as 28-day (from diagnosis of cardiogenic shock) mortality retrospectively. Kaplan-Meier survival analysis was used to compare the 28-day survival rates of patients of different genders/with or without IABP treatment. Adjustment for age, systolic blood pressure, ST segment elevation myocardial infarction, dual antiplatelet, coma, APACHEⅡ score and SAPSⅡ score, Cox regression analysis was used to detect the affect of IABP treatment on the risk of all-cause mortality in different crowd, and using Z test to evaluate the modification effect of gender on IABP treatment efficacy. Results: A total of 209 patients were included in this study, with 148 males (80 (54.05%) cases received IABP support) and 61 females (22 (36.06%) cases received IABP support). A total of 102 patients received IABP treatment. The 28-day survival rate of male patients was higher than that of females (39.2% (58/148) vs. 26.2% (16/61), Log-rank P=0.034). The 28-day survival rate of patients receiving IABP was significantly higher than that of non-IABP groups (46.1% (47/102) vs. 25.2% (27/107), Log-rank P=0.001 7). Among female patients, there was no statistically significant difference in 28-day survival rate between those who received IABP and those who did not receive IABP (P=0.889). While in male patients, the 28-day survival rate of those who received IABP was higher than that of those who did not receive IABP (51.2% (41/80) vs. 25.0% (17/68), P=0.001). The survival rate of male patients treated with IABP was higher than that of male patients who did not receive IABP, female patients who did not receive IABP and female patients who received IABP (all P<0.05). After multiple regression analysis and adjustment of confounding factors, it was found that IABP implantation can significantly reduce the 28-day mortality risk in male patients (HR=0.44, 95%CI 0.25-0.77 P=0.004). While it had no inpact on the death risk in female patients(P= 0.401). The impact of IABP implantation in patients of different genders was significantly different (Z=-2.32, P=0.020). Conclusion: In AMI patients complicating cardiogenic shock, there is a gender difference in the impact of IABP implantation on the 28-day mortality risk, and protective effects are seen only in men. 目的: 探讨主动脉内球囊反搏(IABP)对急性心肌梗死(AMI)并发心原性休克患者短期生存率的影响是否具有性别差异。 方法: 纳入2012年6月至2018年5月间阜外医院收治的AMI合并心原性休克患者共209例,回顾性收集其临床资料进行分析,依据性别及是否接受IABP治疗对患者进行分组。观察终点为28 d(自心原性休克诊断明确起)的生存情况。采用Kaplan-Meier生存分析法比较不同性别/接受IABP治疗与否患者的28 d生存率。调整年龄、收缩压、ST段抬高型心肌梗死、双联抗血小板、昏迷、APACHEⅡ评分及SAPSⅡ评分等因素,采用Cox回归分析在不同人群中IABP治疗是否影响患者的28 d全因死亡风险,应用Z检验评估性别因素对IABP治疗效果的修饰作用。 结果: 共纳入209例患者,其中男性148例[80例(54.05%)接受IABP支持],女性61例[22例(36.06%)接受IABP支持]。接受IABP治疗者102例。男性患者的28 d生存率高于女性[39.2%(58/148)比26.2%(16/61),Log-rank P=0.034]。接受IABP治疗患者的28 d生存率高于未接受IABP者[46.1%(47/102)比25.2 %(27/107),Log-rank P=0.001 7]。在女性患者中,接受IABP与未接受IABP患者的28 d生存率差异无统计学意义(P=0.889);而在男性患者中,接受IABP者的28 d生存率高于未接受IABP者[51.2%(41/80)比25.0%(17/68),P=0.001]。接受IABP治疗的男性患者的28 d生存率高于未接受IABP治疗的男性患者及接受或未接受IABP的女性患者(P均>0.05)。调整混杂因素后,Cox回归分析结果显示,不同性别患者中,IABP对28 d全因死亡风险的影响并不一致,在男性患者中IABP治疗可降低28 d全因死亡风险(HR=0.44,95%CI 0.25~0.77,P=0.004),而在女性患者中IABP治疗对28 d全因死亡风险无影响(P=0.401),性别与IABP疗效存在交互作用(Z值=-2.32,P=0.020)。 结论: IABP支持对患者28 d死亡风险的影响存在性别差异,仅在男性患者中表现出保护作用。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Guo C, Teng HB, Zhang J, et al. [Gender difference in efficacy of intra-aortic balloon pump in acute myocardial infarction patients complicating with cardiogenic shock]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32847324. doi:10.3760/cma.j.cn112148-20190912-00563

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。